Next Article in Journal
Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?
Next Article in Special Issue
The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC
Previous Article in Journal
Stereotactic Radiosurgery for Lung Cancer with a Risk-Adapted Strategy Using the Volumetric Modulated Arc Therapy Technique: A Single Arm Phase II Study
Previous Article in Special Issue
Myofibroblastic CAF Density, Not Activated Stroma Index, Indicates Prognosis after Neoadjuvant Therapy of Pancreatic Carcinoma
 
 
Review
Peer-Review Record

Heterogeneity of Cancer-Associated Fibroblasts and the Tumor Immune Microenvironment in Pancreatic Cancer

Cancers 2022, 14(16), 3994; https://doi.org/10.3390/cancers14163994
by Tomohiko Shinkawa, Kenoki Ohuchida * and Masafumi Nakamura *
Reviewer 1:
Reviewer 2:
Cancers 2022, 14(16), 3994; https://doi.org/10.3390/cancers14163994
Submission received: 28 July 2022 / Revised: 16 August 2022 / Accepted: 16 August 2022 / Published: 18 August 2022
(This article belongs to the Special Issue Tumor Microenvironment and Pancreatic Cancer)

Round 1

Reviewer 1 Report

The manuscript “Heterogeneity of cancer-associated fibroblasts and the tumor immune microenvironment in pancreatic cancer” by Tomohiko Shinkawa et al. is a review article which summarizes state-of-knowledge for Cancer-Associated Fibroblasts (CAFs) and their role in pancreatic cancer.

The review summarizes the possible dual role of CAFs in PDAC for which are so difficult to understand its role in PDAC progression and are difficult therapeutic target. The review contains several figures which are always helpful for easier understanding. I appreciated very much the last paragraph about clinical relevance of CAFs in pancreatic cancer, and possible design of stroma-targeting therapies.

In conclusion, I would recommend the Editor to accept the manuscript for publication in this Journal, at the present form.

 

Author Response

Reviewer 1: The manuscript “Heterogeneity of cancer-associated fibroblasts and the tumor immune microenvironment in pancreatic cancer” by Tomohiko Shinkawa et al. is a review article which summarizes state-of-knowledge for Cancer-Associated Fibroblasts (CAFs) and their role in pancreatic cancer.

The review summarizes the possible dual role of CAFs in PDAC for which are so difficult to understand its role in PDAC progression and are difficult therapeutic target. The review contains several figures which are always helpful for easier understanding. I appreciated very much the last paragraph about clinical relevance of CAFs in pancreatic cancer, and possible design of stroma-targeting therapies.

In conclusion, I would recommend the Editor to accept the manuscript for publication in this Journal, at the present form.

 

Response 1: The authors would like to thank the Reviewer for their comments.

Reviewer 2 Report

This review by Shinkawa et al. on the tumor microenvironment of Pancreatic Ductal AdenoCarcinoma (PDAC) focuses on the roles of Cancer-Associated Fibroblasts (CAF). The review is very extensive and the different newly described populations of CAF (apCAF, myCAF, iCAF) are well described. Good emphasis on single-cell RNA sequencing studies and also on the biological implications of the CAF for PDAC tumorigenesis and response/resistance to therapy. The figures are clear and helpful. I must commend the authors on a very well executed review.

Author Response

Reviewer 2: This review by Shinkawa et al. on the tumor microenvironment of Pancreatic Ductal AdenoCarcinoma (PDAC) focuses on the roles of Cancer-Associated Fibroblasts (CAF). The review is very extensive and the different newly described populations of CAF (apCAF, myCAF, iCAF) are well described. Good emphasis on single-cell RNA sequencing studies and also on the biological implications of the CAF for PDAC tumorigenesis and response/resistance to therapy. The figures are clear and helpful. I must commend the authors on a very well executed review.

 

Response 2: The authors would like to thank the Reviewer for their comments.

Back to TopTop